Published in J Clin Gastroenterol on February 01, 2007
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study | NCT02081404
The use of medication after laparoscopic antireflux surgery. Surg Endosc (2009) 3.09
Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg (2008) 2.06
Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia. Gut (2009) 1.59
Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2010) 1.33
Current knowledge on esophageal atresia. World J Gastroenterol (2012) 1.24
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 1.20
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am J Gastroenterol (2009) 1.14
Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. BMC Gastroenterol (2011) 1.11
Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol (2012) 1.09
Technical problems produced by the Bravo pH test in nonerosive reflux disease patients. World J Gastroenterol (2010) 1.06
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04
Strategy for treatment of nonerosive reflux disease in Asia. World J Gastroenterol (2008) 0.99
Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.99
Diagnostic Utility of Impedance-pH Monitoring in Refractory Non-erosive Reflux Disease. J Neurogastroenterol Motil (2014) 0.98
Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol (2013) 0.97
Association of sleep dysfunction and emotional status with gastroesophageal reflux disease in Korea. J Neurogastroenterol Motil (2013) 0.95
Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol (2015) 0.94
Detection of gastroesophageal reflux esophagitis using 2-fluoro-2-deoxy-d-glucose positron emission tomography. ScientificWorldJournal (2012) 0.92
Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): a study using intraluminal impedance monitoring. Dig Dis Sci (2008) 0.90
A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scand J Gastroenterol (2014) 0.90
Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa. J Neurogastroenterol Motil (2010) 0.89
HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes. Am J Physiol Gastrointest Liver Physiol (2010) 0.88
Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol (2012) 0.87
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective. PLoS One (2014) 0.87
Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract (2013) 0.83
Differences in clinical characteristics between patients with non-erosive reflux disease and erosive esophagitis in Korea. J Korean Med Sci (2010) 0.83
Lifestyle change influences on GERD in Japan: a study of participants in a health examination program. Dig Dis Sci (2011) 0.83
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. World J Gastroenterol (2012) 0.82
Dietary intake and risk for reflux esophagitis: a case-control study. Gastroenterol Res Pract (2013) 0.81
Atypical symptoms in patients with gastroesophageal reflux disease. J Neurogastroenterol Motil (2012) 0.81
Prevalence and risk factor of erosive esophagitis observed in Korean National Cancer Screening Program. J Korean Med Sci (2011) 0.80
Gastric emptying evaluation in children with erosive gastroesophageal reflux disease. Pediatr Surg Int (2010) 0.79
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol (2016) 0.79
Distinction between patients with non-erosive reflux disease and functional heartburn. Ann Gastroenterol (2013) 0.79
Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease. World J Gastroenterol (2013) 0.79
Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients. BMC Gastroenterol (2014) 0.79
GERD: are functional heartburn and functional dyspepsia one disorder? Nat Rev Gastroenterol Hepatol (2010) 0.79
Recurrence and Its Impact on the Health-related Quality of Life in Patients with Gastroesophageal Reflux Disease: A Prospective Follow-up Analysis. J Neurogastroenterol Motil (2016) 0.78
Gastrointestinal morbidity in obesity. Ann N Y Acad Sci (2014) 0.77
Impact of PPIs on patient focused symptomatology in GERD. Ther Clin Risk Manag (2008) 0.76
4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease. PLoS One (2011) 0.76
Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. World J Gastrointest Pathophysiol (2011) 0.76
Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center. J Neurogastroenterol Motil (2010) 0.76
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol (2017) 0.76
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease. Therap Adv Gastroenterol (2017) 0.75
Evaluations of life style factors and the severity of Gastroesophageal reflux disease; a case-control study. Int J Mol Epidemiol Genet (2015) 0.75
Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia. Biomed Rep (2016) 0.75
The Effect of Zinc Supplementationon the Symptoms of Gastroesophageal Reflux Disease; a Randomized Clinical Trial. Middle East J Dig Dis (2016) 0.75
Gastrointestinal Complications of Obesity. Gastroenterology (2017) 0.75
Reflux Hypersensitivity: A New Functional Esophageal Disorder. J Neurogastroenterol Motil (2017) 0.75
Anxiety and depression in patients with gastroesophageal reflux disorder. Electron Physician (2017) 0.75